Summary:
- The article addresses the critical importance of source verification and quality control when procuring biological materials such as peptides, exosomes, and stem cells for therapeutic use.
- It highlights the risks associated with the unregulated market for regenerative medicine products, emphasizing the potential for contamination, lack of potency, and health hazards.
- The text underscores the necessity of consulting licensed medical professionals and ensuring products are sourced from reputable, certified laboratories to maintain patient safety and clinical efficacy.